These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 32071440)

  • 1. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.
    Klein RD; Hultgren SJ
    Nat Rev Microbiol; 2020 Apr; 18(4):211-226. PubMed ID: 32071440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaching the End of the Line: Urinary Tract Infections.
    Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bacterial urinary tract infections: presence and future.
    Wagenlehner FM; Naber KG
    Eur Urol; 2006 Feb; 49(2):235-44. PubMed ID: 16413668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment.
    Tofte N; Nielsen AC; Trøstrup H; Andersen CB; Von Linstow M; Hansen B; Biering-Sørensen F; Høiby N; Moser C
    APMIS; 2017 Apr; 125(4):385-391. PubMed ID: 28407430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract infections: epidemiology, mechanisms of infection and treatment options.
    Flores-Mireles AL; Walker JN; Caparon M; Hultgren SJ
    Nat Rev Microbiol; 2015 May; 13(5):269-84. PubMed ID: 25853778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on uncomplicated urinary tract infections in women.
    Wagenlehner FM; Weidner W; Naber KG
    Curr Opin Urol; 2009 Jul; 19(4):368-74. PubMed ID: 19451818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients.
    Giannakopoulos X; Sakkas H; Ragos V; Tsiambas E; Bozidis P; M Evangelou A; Papadopoulou C; Petrogiannopoulos L; Sofikitis N
    J BUON; 2019; 24(5):1768-1775. PubMed ID: 31786836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
    BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with community-acquired urinary tract infections among adults attending assessment centre, Mulago Hospital Uganda.
    Kabugo D; Kizito S; Ashok DD; Graham KA; Nabimba R; Namunana S; Kabaka MR; Achan B; Najjuka FC
    Afr Health Sci; 2016 Dec; 16(4):1131-1142. PubMed ID: 28479906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing prevalence of antimicrobial resistance in urinary tract infections of neurological patients, Seoul, South Korea, 2007-2016.
    Shin HR; Moon J; Lee HS; Ahn SJ; Kim TJ; Jun JS; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Int J Infect Dis; 2019 Jul; 84():109-115. PubMed ID: 31077804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guideline-based treatment of urinary tract infections].
    Ternes B; Wagenlehner FME
    Urologe A; 2020 May; 59(5):550-558. PubMed ID: 32240318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infective treatment of bacterial urinary tract infections.
    Wagenlehner FM; Pilatz A; Naber KG; Perletti G; Wagenlehner CM; Weidner W
    Curr Med Chem; 2008; 15(14):1412-27. PubMed ID: 18537619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
    Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG
    Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of urinary tract infections in children in an era of increasing antimicrobial resistance.
    Robinson JL; Le Saux N
    Expert Rev Anti Infect Ther; 2016 Sep; 14(9):809-16. PubMed ID: 27348347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
    Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel management of urinary tract infections.
    Storm DW; Patel AS; Koff SA; Justice SS
    Curr Opin Urol; 2011 Jul; 21(4):328-33. PubMed ID: 21519273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
    O'Brien VP; Hannan TJ; Nielsen HV; Hultgren SJ
    Microbiol Spectr; 2016 Feb; 4(1):. PubMed ID: 26999391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.